A detailed history of Squarepoint Ops LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 24,838 shares of VNDA stock, worth $123,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,838
Previous 79,030 68.57%
Holding current value
$123,693
Previous $446,000 73.99%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.61 - $6.34 $249,825 - $343,577
-54,192 Reduced 68.57%
24,838 $116,000
Q2 2024

Aug 14, 2024

SELL
$3.91 - $6.5 $612,200 - $1.02 Million
-156,573 Reduced 66.46%
79,030 $446,000
Q1 2024

May 15, 2024

SELL
$3.47 - $4.61 $597,395 - $793,657
-172,160 Reduced 42.22%
235,603 $968,000
Q4 2023

Feb 14, 2024

BUY
$3.38 - $4.58 $1.16 Million - $1.57 Million
342,226 Added 522.19%
407,763 $1.72 Million
Q2 2023

Aug 14, 2023

BUY
$5.9 - $6.95 $386,668 - $455,482
65,537 New
65,537 $431,000
Q4 2022

Feb 14, 2023

BUY
$6.87 - $10.96 $103,867 - $165,704
15,119 New
15,119 $111,000
Q2 2022

Aug 15, 2022

SELL
$9.31 - $11.84 $93,807 - $119,299
-10,076 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$10.84 - $16.55 $846,788 - $1.29 Million
-78,117 Reduced 88.58%
10,076 $114,000
Q4 2021

Feb 14, 2022

BUY
$15.69 - $21.14 $722,242 - $973,116
46,032 Added 109.18%
88,193 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$15.35 - $21.27 $173,378 - $240,244
11,295 Added 36.59%
42,161 $723,000
Q2 2021

Aug 16, 2021

BUY
$15.71 - $21.51 $243,222 - $333,017
15,482 Added 100.64%
30,866 $664,000
Q1 2021

May 17, 2021

SELL
$13.42 - $20.28 $166,381 - $251,431
-12,398 Reduced 44.63%
15,384 $231,000
Q4 2020

Feb 16, 2021

BUY
$9.77 - $13.81 $271,430 - $383,669
27,782 New
27,782 $365,000
Q3 2020

Nov 16, 2020

SELL
$9.32 - $12.02 $705,747 - $910,202
-75,724 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$9.66 - $12.02 $51,642 - $64,258
-5,346 Reduced 6.59%
75,724 $866,000
Q1 2020

May 15, 2020

SELL
$7.5 - $16.8 $271,192 - $607,471
-36,159 Reduced 30.84%
81,070 $840,000
Q4 2019

Feb 14, 2020

SELL
$12.38 - $17.47 $1.75 Million - $2.46 Million
-141,087 Reduced 54.62%
117,229 $1.92 Million
Q3 2019

Nov 14, 2019

BUY
$12.27 - $15.79 $2.15 Million - $2.77 Million
175,213 Added 210.84%
258,316 $3.43 Million
Q2 2019

Aug 14, 2019

SELL
$13.37 - $18.85 $2.86 Million - $4.03 Million
-213,765 Reduced 72.01%
83,103 $1.17 Million
Q1 2019

May 15, 2019

BUY
$17.59 - $31.05 $2.37 Million - $4.19 Million
134,984 Added 83.38%
296,868 $5.46 Million
Q4 2018

Feb 14, 2019

BUY
$18.97 - $31.47 $1.03 Million - $1.71 Million
54,269 Added 50.43%
161,884 $4.23 Million
Q3 2018

Nov 14, 2018

BUY
$18.25 - $23.0 $201,023 - $253,345
11,015 Added 11.4%
107,615 $2.47 Million
Q2 2018

Aug 14, 2018

SELL
$13.95 - $19.15 $17,116 - $23,497
-1,227 Reduced 1.25%
96,600 $1.84 Million
Q1 2018

May 15, 2018

BUY
$14.05 - $20.2 $747,923 - $1.08 Million
53,233 Added 119.37%
97,827 $1.65 Million
Q4 2017

Feb 14, 2018

BUY
$12.85 - $18.1 $12,168 - $17,140
947 Added 2.17%
44,594 $678,000
Q3 2017

Nov 14, 2017

BUY
$15.4 - $18.85 $672,163 - $822,745
43,647
43,647 $781,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $282M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.